Related Experiment Video

Updated: Aug 17, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Renal osteodystrophy in hemodialysis patients

H Oda1, N Yorioka, A Takemasa

  • 1Second Department of Internal Medicine, Hiroshima University School of Medicine.

Hiroshima Journal of Medical Sciences
|September 1, 1995
PubMed

Insights

Chronic hemodialysis patients experience greater bone loss, particularly women post-menopause. Age and dialysis duration are key factors, with specific biomarkers influencing bone density in males and females. Controlling these biomarkers can help prevent bone loss.

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Background:

  • Chronic kidney disease patients on hemodialysis often suffer from bone loss.
  • Medications like phosphate binders and 1 alpha-OH D3 are used, but bone loss patterns require further investigation.

Purpose of the Study:

  • To investigate bone loss patterns in hemodialysis patients.
  • To identify clinical factors and biomarkers associated with bone loss in these patients.

Main Methods:

  • Studied 88 hemodialysis patients and 60 controls.
  • Measured bone mass indices: metacarpal index (MCI), sigma gray scale/diameter (sigma GS/D), and bone mineral content (BMC).
  • Correlated bone mass indices with clinical factors: age, dialysis duration, serum phosphate (P), calcium (Ca), carboxy-terminal fragments of parathyroid hormone (C-PTH), osteocalcin (OC), alkaline phosphatase (ALP), and Ca x P.

Main Results:

  • Hemodialysis patients exhibited greater bone loss than controls, accelerated post-menopause in women.
  • Bone mass indices negatively correlated with dialysis duration, C-PTH, and OC in males.
  • BMC in females negatively correlated with P, C-PTH, and Ca x P.

Conclusions:

  • Age and hemodialysis duration are primary drivers of bone loss in both male and female patients.
  • C-PTH and OC are significant for skeletal bone loss in males; P, C-PTH, and Ca x P for trabecular bone loss in females.
  • Controlling C-PTH, OC, P, and Ca x P levels is recommended to prevent bone loss in hemodialysis patients.

More Related Videos

Osteoclast Derivation from Mouse Bone Marrow06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model08:53

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

Related Concept Videos

What is the Skeletal System?01:02

What is the Skeletal System?

Overview
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...